Back to search

Aristotle University Of Thessaloniki (AUTH)

Μελέτη του γονιδιακού πολυμορφισμού rs13017968 του γονιδίου SLC8A1 και των αιματολογικών παραμέτρων ως προγνωστικοί δείκτες στη νόσο Kawasaki

Abstract

dc:description

Kawasaki disease, also known as mucocutaneous lymph node syndrome, is an acute self limiting vasculitis primarily affecting medium and small arteries, particularly the coronary vessels. It is widely recognized as the leading cause of acquired heart disease in childhood and predominantly affects infants and children below the age of 5 years. The exact cause of Kawasaki disease remains unclear. Prompt initiation of treatment is crucial, as the disease can lead to serious complications if left untreated. Approximately 30% of patients develop coronary artery aneurysms, which are abnormal dilations of the coronary arteries. In Greece, the frequency of Kawasaki disease between 2000 and 2010, was reported to be 3.16 per 100,000 children under 14 years of age. Kawasaki disease can manifest in three different types: typical, incomplete, and non-typical. Accurate and timely diagnosis is of utmost importance as the course and prognosis of the disease depend on the prompt initiation of treatment. The primary treatment for Kawasaki disease is the intravenous administration of gamma-globulin (IVIG) along with high-dose aspirin. This therapy should be initiated immediately if the patient meets the diagnostic criteria. IVIG therapy has been shown to significantly reduce the risk of developing coronary aneurysms from 25% to less than 5%. Several studies have been conducted to identify possible biomarkers that can lead to Kawasaki disease diagnosis and predict its outcome. These include inflammation markers, immune response and protein markers, imaging findings, but also genetic markers. Recently, three single nucleotide polymorphisms in SLC8A1 (rs10490051, rs13017968, and rs12989852) were found to be correlated with Kawasaki disease. Among these, rs13017968 is particularly interesting, as it has shown a significant association with the risk of developing coronary aneurysms in patients with Kawasaki. Regarding protein markers, previous studies have found that the ratio of the mean platelet volume to the absolute number of lymphocytes (MPVLR) significantly correlates with the disease. Based on the above finding, the present study aimed to examine the association between the ratio of mean platelet volume to the absolute number of lymphocytes (MPVLR) and the risk of developing Kawasaki disease and coronary artery aneurysms in Kawasaki patients. An additional aim of this study was to investigate the role of the genetic polymorphism rs13017968 in children with Kawasaki and control subjects, as well as to determine the potential of rs13017968 as a prognostic marker for the development of coronary aneurysms in Kawasaki patients. This study was a case-control study conducted at the 2nd Department of Pediatrics at AHEPA University hospital in Thessaloniki. The study was performed after obtaining approval of the responsible scientific board. The study included a total of 60 children up to 16 years old who had been diagnosed with Kawasaki disease. The diagnosis of Kawasaki disease was based on the criteria for typical, incomplete, and non-typical Kawasaki. Additionally, 107 healthy children between 6 and 16 years old who were registered in the emergency unit of the hospital were included as the control group. All patients with Kawasaki disease received treatment with intravenous immunoglobulin (IVIG). Demographic information, genotypic and phenotypic characteristics, and various hematological parameters were collected as part of the study. Overall, the study analyzed 59 out of 60 patients with one patient excluded as an outlier and 107 control subjects. The mean age of the control subjects (139.38 months) was significantly higher than that of the patients (37.36 μήνες) (t=19.041, p<0.01). The majority of the patients (79.7%) exhibited typical symptoms of Kawasaki disease, while a smaller percentage (18.6%) showed atypical symptoms. Only one patient had symptoms of incomplete Kawasaki. Among the patients 33.9% developed coronary artery aneurysms, and 22.0% presented with pericardial fluid. The majority of patients (78.0%) received one dose of IVIG while the remaining patients received two doses. The study did not find a significant correlation between rs13017968 (a specific genetic marker) and the occurrence of Kawasaki disease (χ2=0.162, p=0.922) nor its correlation with the development of coronary artery aneurysm (χ2=4.612, p=0.096). Significant differences were observed in all hematological parameters tested. The MPVLR was significantly lower in patients (3.56 ± 2.24) compared to control subjects (4.58 ± 1.60) (t=3.087, p=0.003). This difference was primarily due to lower values of the mean platelet volume and a correspondingly lower number of lymphocytes. The MPVLR is calculated as a ratio of these two parameters. No significant relationship was found between the MPVLR and the development of coronary artery aneurysms. Consistent with previous data, the study found that boys were more likely to develop coronary artery aneurysms. To predict patients with Kawasaki disease, a logistic regression model was used. The results of this analysis showed a significant association of age (OR=0.942, p=0.003), white blood cell count (WBC) before IVIG treatment (OR=1.001, p=0.001), hematocrit value (HT) before IVIG treatment (OR=0.683, p=0.012), and platelet distribution width (PDW) before IVIG treatment (OR=2.232, p=0.054) with the likelihood of Kawasaki disease. The sensitivity, specificity, and accuracy of the model were 82.4%, 83.9%, and 83.8%, respectively. The model chosen in this study was statistically significant (χ2=28.814, p<0.01), with satisfactory specificity (99.1%) and sensitivity (94.9%), correctly classifying the result for 97.6% of cases. Because of the relatively small sample size of this study, the results should be interpreted with caution. Although the rarity of the disease justifies the limited number of participants, it also restricted the ability to perform certain statistical calculations and may limit the generalizability of the findings. Therefore, further studies including a larger sample or multicenter studies are required to clarify the roles of rs13017968 and MPVLR in Kawasaki disease. This would increase the statistical power and provide more robust conclusions.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Sapountzi, Evdoxia
  • Σαπουντζή, Ευδοξία

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/54219

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Sapountzi, Evdoxia; Σαπουντζή, Ευδοξία. Μελέτη του γονιδιακού πολυμορφισμού rs13017968 του γονιδίου SLC8A1 και των αιματολογικών παραμέτρων ως προγνωστικοί δείκτες στη νόσο Kawasaki. Aristotle University Of Thessaloniki (AUTH), 2023. http://hdl.handle.net/10442/hedi/54219